美股A股
StockGist
Back
8-K2026-03-11· grok-4-1-fast-non-reasoning

RLAY · Relay Therapeutics, Inc.

0001193125-26-102178

SEC filing

Summary

Relay Therapeutics, Inc. amended its bylaws, with the Board of Directors approving the Second Amended and Restated Bylaws on March 6, 2026. The filing includes Exhibit 3.1 containing the bylaws and was submitted on March 11, 2026.

Key takeaways